Prophase Labs

PRPH · NASDAQ

$0.0094+$0.0009 (+10.59%)TodayMarket closed ·
Prev close $0.0085

About PRPH

ProPhase Labs, Inc. is a medical science and technology company, which engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer healthcare products and dietary supplements. The company is headquartered in New York City, New York. The firm is engaged in providing whole genome sequencing solutions, diagnostic development, such as its potentially life-saving test for the early detection of esophageal cancer and a direct-to-consumer marketing platform for OTC dietary supplements. The company develops, manufactures, and commercializes health and wellness solutions. Its Diagnostic services segment provides diagnostic information services to a range of customers in the United States, including health plans, third-party payers and government organizations. Its Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and provides personal genomics products and services. The firm also develops and markets dietary supplements under the TK Supplement brand, which includes Legendz XL and Triple Edge XL.

Employees
96
Headquarters
New York City, New York
Listed
Jan 16, 1984
Sector
Health Care
Industry
Pharmaceuticals

Leadership

Prophase Labs executives
NameTitleSince
Ted Karkus—2009
Steven Plumb——
Carolina Abenante——
Louis Gleckel——

Revenue by product and region

Fiscal year ended Dec 31, 2022: $122.65M total revenue

By product

  • Diagnostic services$108.33M88.3%
  • Consumer products$14.32M11.7%

Similar companies

Companies in the same industry as Prophase Labs

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.